摘要:
A process for preparing .alpha.,.beta.-unsaturated aldehydes of the general formula (I) ##STR1## in which R.sup.1, R.sup.2 and R.sup.3 are independently a hydrogen atom, or an alkyl or alkenyl group with or without being substituted with a lower acyloxy group. The aldehyde of the general formula (I) is prepared by reaction between an allylic chloride of the following general formula (IIa) ##STR2## in which R.sup.1, R.sup.2 and R.sup.3 have, respectively, the same meanings as defined above, and an amine oxide selected from the group consisting of tri(lower alkyl)amine N-oxides of the formula,R.sub.3.sup.4 N.sup.+ O.sup.-,in which R.sup.4 represents a lower alkyl group having from 2 to 4 carbon atoms, and N-lower alkylmorpholine N-oxides of the following formula ##STR3## in which R.sup.5 represents a lower alkyl group having from 1 to 4 carbon atoms. Alternatively, the aldehyde of the formula (I) is obtained by reaction between an allylic chloride of the following general formula (IIb) ##STR4## in which R.sup.1, R.sup.2 and R.sup.3 have, respectively, the same meanings as defined above, and an amine oxide selected from the group consisting of tri(lower alkyl)amine N-oxides of the formula,R.sub.3.sup.4 N.sup.+ O.sup.-,in which R.sup.4 has the same meaning as defined above, and N-lower alkylmorpholine N-oxides of the following formula ##STR5## in which R.sup.5 has the same meaning as defined above, in the presence of an alkali metal iodide or a copper halide.
摘要:
Novel chroman compounds which have excellent antioxidant activity and/or analgesic activity or serve as precursors for such active compounds are provided. There are also provided uses of these active compounds as an antioxidant and/or analgesic.
摘要:
Novel 3,4-dihydrobenzopyran compounds of the formula: ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are each hydrogen or nicotinoyl group and at least one of them is nicotinoyl group, m is an integer of 0, 1 or 2, and n is an integer of 0 or 1, which is useful for prophylaxis and treatment of hyperlipemia and the compounds wherein R.sup.1 and R.sup.3 being nicotinoyl group and n is 0 being also effective for prophylaxis and treatment of hepatic diseases, and pharmaceutical composition containing said compounds as an active ingredient.
摘要:
A process for obtaining a stereospecific nerolidol at the .DELTA..sup.6 -position thereof by rectifying a mixture of .DELTA..sup.6 -cis-nerolidol and .DELTA..sup.6 -trans-nerolidol in rectification column having from 10 to 100 theoretical plates with a reflux ratio of from 2 to 200 at a temperature below 230.degree. C. under reduced pressure to separate each stereospecific nerolidol from said mixture.
摘要:
Novel pesticidal compositions are comprised of a 2,2-dimethyl-3-(substituted ethyl)cyclopropanecarboxylic acid ester as the active ingredient, said cyclopropanecarboxylate having the structural formula: ##STR1## wherein X, Y and Z are the same or different and at least two of same are chlorine or bromine, with the remaining one being hydrogen, methyl, chlorine or bromine; R is an alcohol residue represented by one of the following structural formulae (II), (III), (IV) and (V): ##STR2## where A represents hydrogen, cyano, ethynyl or thiocarbamoyl; Q is hydrogen, chlorine, bromine, fluorine, methyl or trifluoromethyl; R.sup.1 is propargyl or benzyl; R.sup.2 represents 2-halogeno-3-phenyl-1-propen-1-yl, (dihalogenovinyloxy)phenyl, benzylphenyl, phthalimido, thiophthalimido, di- or tetrahydrophthalimido or dialkylmaleimido; R.sup.3 represents allyl, 2,4-pentadienyl, propargyl or benzyl.
摘要翻译:新型杀虫剂组合物由2,2-二甲基-3-(取代的乙基)环丙烷甲酸酯作为活性成分组成,所述环丙烷羧酸酯具有以下结构式:其中X,Y和Z相同或不同, 其中至少两个是氯或溴,剩下的一个是氢,甲基,氯或溴; R是由以下结构式(II),(III),(IV)和(V)之一表示的醇残基:其中A表示氢,氰基,乙炔基或硫代氨基甲酰基; Q是氢,氯,溴,氟,甲基或三氟甲基; R1是炔丙基或苄基; R 2表示2-卤代-3-苯基-1-丙烯-1-基,(二卤代乙烯基氧基)苯基,苄基苯基,苯二甲酰亚氨基,硫代邻苯二甲酰亚氨基,二或四氢邻苯二甲酰亚氨基或二烷基马来酰亚胺; R3表示烯丙基,2,4-戊二烯基,炔丙基或苄基。
摘要:
Novel pesticidal compositions are comprised of a 2,2-dimethyl-3-(substituted ethyl)cyclopropanecarboxylic acid ester as the active ingredient, said cyclopropanecarboxylate having the structural formula: ##STR1## wherein X, Y and Z are the same or different and at least two of same are chlorine or bromine, with the remaining one being hydrogen, methyl, chlorine or bromine; R is an alcohol residue represented by one of the following structural formulae (II), (III), (IV) and (V): ##STR2## where A represents hydrogen, cyano, ethynyl or thiocarbamoyl; Q is hydrogen, chlorine, bromine, fluorine, methyl or trifluoromethyl; R.sup.1 is propargyl or benzyl; R.sup.2 represents 2-halogeno-3-phenyl-1-propen-1-yl, (dihalogenovinyloxy)phenyl, benzylphenyl, phthalimido, thiophthalimido, di- or tetrahydrophthalimido or dialkylmaleimido; R.sup.3 represents allyl, 2,4-pentadienyl, propargyl or benzyl.
摘要翻译:新型杀虫剂组合物由2,2-二甲基-3-(取代的乙基)环丙烷甲酸酯作为活性成分组成,所述环丙烷羧酸酯具有以下结构式:其中X,Y和Z相同或不同, 其中至少两个是氯或溴,剩下的一个是氢,甲基,氯或溴; (II),(IV)和(V)表示的醇残基:R是由下列结构式(II),(III),(IV)和(V)之一表示的醇残基: (Ⅴ)其中A代表氢,氰基,乙炔基或硫代氨基甲酰基; Q是氢,氯,溴,氟,甲基或三氟甲基; R1是炔丙基或苄基; R 2表示2-卤代-3-苯基-1-丙烯-1-基,(二卤代乙烯基氧基)苯基,苄基苯基,苯二甲酰亚氨基,硫代邻苯二甲酰亚氨基,二或四氢邻苯二甲酰亚氨基或二烷基马来酰亚胺; R3表示烯丙基,2,4-戊二烯基,炔丙基或苄基。
摘要:
A process for preparing stereospecific farnesylacetic acid and ester thereof by rectifying a mixture of .DELTA..sup.4,8 -trans- and .DELTA..sup.4 -cis-.DELTA..sup.8 -trans-farnesylacetic acids or esters thereof or .DELTA..sup.4,8 -trans- and .DELTA..sup.4 -cis-.DELTA..sup.8 -trans-farnesylacetic acid or esters thereof or a mixture of four isomers of the said farnesylacetic acids or esters thereof.
摘要:
2-Substituted or unsubstituted geranyl actic acid esters represented by the general formula [I], ##STR1## wherein R.sub.1 represents a hydrogen atom or a hydrocarbon and R.sub.5 is the same as R.sub.2, R.sub.3 or R.sub.4 hereinafter defined, are prepared by reacting linalool (II) with 2-substituted or unsubstituted ortho acetic acid ester derivatives represented by the general formula [III] ##STR2## wherein R.sub.2, R.sub.3 and R.sub.4, which are the same or different, each represents an alkyl group or a cycloalkyl group, in the presence of an acidic catalyst.
摘要:
Novel 2,6,10,15,19,23-hexamethyltetracosa-11,13-diin-10,15-diol derivatives. Such derivatives are prepared by oxydative coupling of 3,7,11-trimethyldodeca-1-in-3-ol derivatives or by ethynylation of 6,10-dimethylundecan-2-on derivatives with diacetylene and used as starting materials for preparing squalane.
摘要:
The present invention provides a double-stranded RNA which inhibits replication of influenza B viruses by RNA interference, in which the double-stranded RNA comprises an RNA having 19 to 25 nucleotides homologous with a part of an mRNA transcribed from a genomic RNA of the influenza B viruses and an antisense RNA thereof.